Federal grants to Steadman Philippon Research Institute
Steadman Philippon Research Institute in Vail, Colorado received $7.6 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Arthritis, Musculoskeletal and Skin Diseases Research, with $2.2 million. In fiscal 2025 it was awarded $1.3 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$7.6 million
- Awards7
- Awarded in FY 2025$1.3 million
- Largest award$2.2 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 5 | $3.1 million |
| FY 2022 | 4 | $1.2 million |
| FY 2023 | 3 | $1.1 million |
| FY 2024 | 2 | $885,557 |
| FY 2025 | 2 | $1.3 million |
Programs that fund Steadman Philippon Research Institute
| Program | Awards | Amount |
|---|---|---|
| Arthritis, Musculoskeletal and Skin Diseases Research | 3 | $2.2 million |
| 21st Century Cures Act: Regenerative Medicine Initiative | 1 | $2.2 million |
| Basic and Applied Scientific Research | 1 | $2.0 million |
| Military Medical Research and Development | 1 | $962,977 |
| Trans-NIH Research Support | 1 | $156,500 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $4.6 million |
| Department of Defense | 2 | $3.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| The use of senolytic and anti-fibrotic agents to improve the beneficial effect of bone marrow stem cells for osteoarthritis - abstract: osteoarthritis (OA) is a progressive joint disease leading to cartilage damage, pain and loss of function. While many stem cell therapies for oa are under investiga | 21st Century Cures Act: Regenerative Medicine Initiative | August 11, 2021 | $2.2 million |
| The use of senolytic agent to improve the benefit of platelet-rich plasma and losartan for treatment of femoroacetabular impingement and labral tear: a pilot study | Basic and Applied Scientific Research | August 20, 2021 | $2.0 million |
| Articular cartilage tissue engineering with human pluripotent stem cells - abstract impairment of articular cartilage function after injury and disease like osteoarthritis (OA), remains a major health problem. One of the major drawbacks of tissue engineering-based therapies for damaged joint articul | Arthritis, Musculoskeletal and Skin Diseases Research | March 17, 2021 | $1.7 million |
| Strategies for improving the quality and efficacy of autologous extracellular vesicles for treating musculoskeletal injuries and disease | Military Medical Research and Development | August 7, 2025 | $962,977 |
| Smart stem cells that autonomously down-modulate tfg-? Signaling for articular cartilage repair - abstract articular cartilage is an important hypovascular tissue structure that, once damaged, does not spontaneously regenerate and often leads to osteoarthritis. Considerable efforts have been made to | Arthritis, Musculoskeletal and Skin Diseases Research | March 11, 2022 | $376,018 |
| The use of senolytic and anti-fibrotic agents to improve the beneficial effect of bone marrow stem cells for osteoarthritis - abstract: osteoarthritis (OA) is a progressive joint disease leading to cartilage damage, pain and loss of function. While many stem cell therapies for oa are under investiga | Arthritis, Musculoskeletal and Skin Diseases Research | August 11, 2021 | $200,000 |
| The use of senolytic and anti-fibrotic agents to improve the beneficial effect of bone marrow stem cells for osteoarthritis - abstract: osteoarthritis (OA) is a progressive joint disease leading to cartilage damage, pain and loss of function. While many stem cell therapies for oa are under investiga | Trans-NIH Research Support | August 12, 2021 | $156,500 |
Questions people ask
How much federal grant money does Steadman Philippon Research Institute get?
$7.6 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Steadman Philippon Research Institute the most?
The Department of Health and Human Services, with $4.6 million in 5 awards. The Department of Defense follow.
What is Steadman Philippon Research Institute's largest federal grant?
$2.2 million under 21st Century Cures Act: Regenerative Medicine Initiative, with its first action in the period on August 11, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Steadman Philippon Research Institute?
Its largest are Arthritis, Musculoskeletal and Skin Diseases Research, 21st Century Cures Act: Regenerative Medicine Initiative and Basic and Applied Scientific Research.
Other grant recipients in Vail
Largest federal grant recipients in Colorado · Federal grants in Colorado